- Report
- July 2023
- 129 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- April 2023
- 165 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- August 2022
- 30 Pages
Global
From €2958EUR$3,250USD£2,536GBP
- Report
- November 2023
- 172 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- February 2024
- 180 Pages
Global
From €4522EUR$4,969USD£3,877GBP
- Report
- May 2023
- 160 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- March 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- January 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2021
- 120 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 80 Pages
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- March 2021
- 120 Pages
Global
From €13647EUR$14,995USD£11,699GBP
- Report
- April 2022
- 80 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
France
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
Germany
From €1365EUR$1,500USD£1,170GBP

Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of drugs used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder. SSRIs work by increasing the amount of serotonin, a neurotransmitter, in the brain. This helps to improve mood and reduce symptoms of mental illness. SSRIs are generally considered to be safer and more effective than other types of antidepressants, and they are often prescribed as a first-line treatment for mental disorders.
The SSRI market is highly competitive, with many pharmaceutical companies offering different brands of SSRIs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. These companies have developed a wide range of SSRIs, including Prozac, Zoloft, Paxil, and Lexapro. Other companies, such as Mylan and Teva, also offer generic versions of SSRIs. Show Less Read more